These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 7688977

  • 21. Appraisal of a new scheme for prenatal screening for Down's syndrome.
    Sheldon TA, Simpson J.
    BMJ; 1991 May 11; 302(6785):1133-6. PubMed ID: 1710520
    [Abstract] [Full Text] [Related]

  • 22. [Prenatal serum screening for Down's syndrome].
    Müller U, Benz R, Krahner-Pilat M, Terinde R.
    Z Geburtshilfe Perinatol; 1992 May 11; 196(3):129-33. PubMed ID: 1379769
    [Abstract] [Full Text] [Related]

  • 23. Value of maternal serum unconjugated oestriol measurement in prenatal screening for Down's syndrome.
    Wald NJ, Kennard A, Watt HC, Smith D.
    Prenat Diagn; 1994 Aug 11; 14(8):699-706. PubMed ID: 7527536
    [Abstract] [Full Text] [Related]

  • 24. A cost-effectiveness analysis of prenatal screening strategies for Down syndrome.
    Odibo AO, Stamilio DM, Nelson DB, Sehdev HM, Macones GA.
    Obstet Gynecol; 2005 Sep 11; 106(3):562-8. PubMed ID: 16135588
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Down's syndrome risk estimates demonstrate considerable heterogeneity despite homogeneity of input.
    Reynolds T, Ellis A, Jones R.
    Ann Clin Biochem; 2004 Nov 11; 41(Pt 6):464-8. PubMed ID: 15588435
    [Abstract] [Full Text] [Related]

  • 32. Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.
    Wald NJ, Kennard A, Densem JW, Cuckle HS, Chard T, Butler L.
    BMJ; 1992 Aug 15; 305(6850):391-4. PubMed ID: 1382768
    [Abstract] [Full Text] [Related]

  • 33. First- and second-trimester evaluation of risk for Down syndrome.
    Ball RH, Caughey AB, Malone FD, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Emig D, D'Alton ME, First and Second Trimester Evaluation of Risk (FASTER) Research Consortium.
    Obstet Gynecol; 2007 Jul 15; 110(1):10-7. PubMed ID: 17601890
    [Abstract] [Full Text] [Related]

  • 34. [Evaluation of the value of triple diagnosis in prenatal medicine].
    Krebs D.
    Zentralbl Gynakol; 1995 Jul 15; 117(3):130-3. PubMed ID: 7537933
    [Abstract] [Full Text] [Related]

  • 35. The impact of maternal serum screening on the birth prevalence of Down's syndrome and the use of amniocentesis and chorionic villus sampling in South Australia.
    Cheffins T, Chan A, Haan EA, Ranieri E, Ryall RG, Keane RJ, Byron-Scott R, Scott H, Gjerde EM, Nguyen AM, Ford JH, Sykes S.
    BJOG; 2000 Dec 15; 107(12):1453-9. PubMed ID: 11192100
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies.
    Bahado-Singh RO, Oz U, Shahabi S, Mahoney MJ, Baumgarten A, Cole LA.
    Am J Obstet Gynecol; 2000 Nov 15; 183(5):1114-8. PubMed ID: 11084551
    [Abstract] [Full Text] [Related]

  • 38. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy].
    Lesin J, Skrablin S, Durić K, Suchanek E, Muzinić D, Kalafatić D, Kuvacić I, Zlopasa G, Plavec A.
    Lijec Vjesn; 2003 Nov 15; 125(3-4):55-60. PubMed ID: 12899094
    [Abstract] [Full Text] [Related]

  • 39. The variation of risk estimates through pregnancy in second trimester maternal serum screening for Down syndrome.
    Christiansen M, Høgdall EV, Larsen SO, Høgdall C.
    Prenat Diagn; 2002 May 15; 22(5):385-7. PubMed ID: 12001192
    [Abstract] [Full Text] [Related]

  • 40. [Prenatal serum screening of aneuploidy and of neural tube defects in the second trimester of pregnancy among the population of Luxembourg. Evaluation of risk by the triple test (AFP+THCG+UE3)].
    Thix J.
    Bull Soc Sci Med Grand Duche Luxemb; 1997 May 15; 134(1):25-9. PubMed ID: 9303823
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.